15.56 USD
▲+2.35+17.79%
盘后 1.60 0.00%
2026-11-06
市值
$10.34M
市盈率
—
EPS
-29.93
股息率
—
52 周区间
5.75 – 23.30
成交量
27.15K
Beta
0.99
目标价
—
52W 低 5.7552W 高 23.30
价格走势
公司简介
InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer’s disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.